238 related articles for article (PubMed ID: 38762474)
1. Vitamin D and vitamin K1 as novel inhibitors of biofilm in Gram-negative bacteria.
Lutfi LL; Shaaban MI; Elshaer SL
BMC Microbiol; 2024 May; 24(1):173. PubMed ID: 38762474
[TBL] [Abstract][Full Text] [Related]
2. Relationship Between Biofilm Formation and Antimicrobial Resistance in Gram-Negative Bacteria.
Cepas V; López Y; Muñoz E; Rolo D; Ardanuy C; Martí S; Xercavins M; Horcajada JP; Bosch J; Soto SM
Microb Drug Resist; 2019; 25(1):72-79. PubMed ID: 30142035
[TBL] [Abstract][Full Text] [Related]
3. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.
Farzi N; Oloomi M; Bahramali G; Siadat SD; Bouzari S
Probiotics Antimicrob Proteins; 2024 Jun; 16(3):796-814. PubMed ID: 37148452
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of tigecycline and comparators against gram-negative bacteria isolated from a tertiary hospital in Alexandria, Egypt.
Mohamed NM; Youssef AA
Microb Drug Resist; 2011 Dec; 17(4):489-95. PubMed ID: 21875338
[TBL] [Abstract][Full Text] [Related]
7. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.
Vidaillac C; Benichou L; Duval RE
Antimicrob Agents Chemother; 2012 Sep; 56(9):4856-61. PubMed ID: 22751540
[TBL] [Abstract][Full Text] [Related]
8. Activity of Norspermidine on Bacterial Biofilms of Multidrug-Resistant Clinical Isolates Associated with Persistent Extremity Wound Infections.
Cardile AP; Woodbury RL; Sanchez CJ; Becerra SC; Garcia RA; Mende K; Wenke JC; Akers KS
Adv Exp Med Biol; 2017; 973():53-70. PubMed ID: 27864804
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
[TBL] [Abstract][Full Text] [Related]
10. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
[TBL] [Abstract][Full Text] [Related]
11. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
Doymaz MZ; Karaaslan E
Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
[No Abstract] [Full Text] [Related]
13. Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies.
Falagas ME; Kastoris AC; Karageorgopoulos DE; Rafailidis PI
Int J Antimicrob Agents; 2009 Aug; 34(2):111-20. PubMed ID: 19403273
[TBL] [Abstract][Full Text] [Related]
14. Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
Zhang X; Gu B; Mei Y; Wen Y; Xia W
J Antibiot (Tokyo); 2015 Feb; 68(2):115-20. PubMed ID: 25182483
[TBL] [Abstract][Full Text] [Related]
15. Multidrug Resistance Related to Biofilm Formation in Acinetobacter baumannii and Klebsiella pneumoniae Clinical Strains from Different Pulsotypes.
de Campos PA; Royer S; Batistão DW; Araújo BF; Queiroz LL; de Brito CS; Gontijo-Filho PP; Ribas RM
Curr Microbiol; 2016 May; 72(5):617-27. PubMed ID: 26846651
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF
Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and Diversity of Intra- and Interhospital Drug-Resistant and Biofilm-Forming
Araújo Lima AV; da Silva SM; do Nascimento Júnior JAA; Correia MDS; Luz AC; Leal-Balbino TC; da Silva MV; Lima JLDC; Maciel MAV; Napoleão TH; Oliveira MBM; Paiva PMG
Microb Drug Resist; 2020 Jul; 26(7):802-814. PubMed ID: 31916896
[No Abstract] [Full Text] [Related]
18. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity.
Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C
Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme.
Karlowsky JA; Lob SH; Kazmierczak KM; Hawser SP; Magnet S; Young K; Motyl MR; Sahm DF
J Antimicrob Chemother; 2018 Jul; 73(7):1872-1879. PubMed ID: 29659861
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of novel chalcones and modulation of virulence factors in hospital strains of Acinetobacter baumannii and Pseudomonas aeruginosa.
Ušjak D; Ivković B; Božić DD; Bošković L; Milenković M
Microb Pathog; 2019 Jun; 131():186-196. PubMed ID: 30980878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
